Effects of neonatal ganglioside GM1 administration on memory in adult and old rats

Pharmacology and Toxicology

Volumn 87, Issue 3, 2000, Pages 120-125

  Silva, Regina H ^a,b   Bergamo, Marcelo ^a   Frussa Filho, Roberto ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SANTO AMARO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE GM1;

ADOLESCENT; ADULTHOOD; AGED; AGING; ANIMAL EXPERIMENT; ARTICLE; AVOIDANCE BEHAVIOR; CONDITIONING; CONTROLLED STUDY; DISCRIMINATION LEARNING; FEMALE; MALE; MEMORY; NERVOUS SYSTEM DEVELOPMENT; NEWBORN; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT;

EID: 0033807722     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0773.2000.pto870304.x     Document Type: Article

References (53)

1. Agnati, L. F., K. Fuxe, F. Benfenati, N. Battistini, I. Zini & G. Toffano: Chronic ganglioside treatment counteracts the biochemical signs of dopamine receptor supersensitivity induced by chronic haloperidol treatment. Neurosc. Letters 1983, 40, 293-297.
2. Alleva, E., L. Aloe & G. Laviola: Pretreatment of young mice with nerve growth factor enhance scopolamine-induced hyperactivity. Der. Brain Res. 1986, 28, 278-281.
3. Altman, J. & K. Sudarshan: Postnatal development of locomotion in the laboratory rat. Animal Behaviour 1975, 23, 896-920.
4. Bartus, R. T., R. L. Dean, B. Beer & A. S. Lippa: The cholinergic hypothesis of geriatric memory dysfunction. Science 1982, 217, 408-417.
5. Bellot, R. G., R. Camarini, M. A. B. F. Vital, J. Palermo-Neto, V. Leyton & R. Frussa-Filho: Monosialoganglioside attenuates the excitatory and behavioural sensitization effects of ethanol. Eur. J. Pharmacol. 1996, 313, 175-179.
6. Bellot, R. G., M. A. B. F. Vital, J. Palermo-Neto & R. Frussa-Filho: Repeated monosialoganglioside administration attenuates behavioral sensitization to amphetamine. Brain Res. 1997, 747, 169-172.
7. Brux, B., K. Ogawa, C. Berndt, C. Wustmann, H. D. Fischer, A. Lun, T. Abe & J. Gross: Effects of postnatal ganglioside administration and hypoxia exposure on the dopamine release from striatal slices, the behaviour and the ganglioside pattern of 2-3 months old rats. J. Neural Transin. 1992, 87, 105-112.
8. Calamandrei, G., A. Valanzano & E. Alleva: NGF and cholinergic control of behavior: Anticipation and enhancement of scopolamine effects in neonatal mice. Dev. Brain Res. 1991, 61, 237-241.
9. Claro, F. T., R. H. Silva & R. Frussa-Filho: Bovine brain phosphatidylserine attenuates scopolamine-induced amnesia. Physiol. Behav. 1999, 67, 551-554.
10. Cuello, A. C., L. Garofalo, R. L. Kenigsberg & D. Maysinger: Gangliosides potentiate in vivo and in vitro effects of nerve growth factor on central cholinergic neurons. Proceedings of the National Academy of Sciences of the United States of America 1989, 866, 2056-2060.
11. Dreyfus, H., J. C. Louis, S. Harth & P. Mandel: Gangliosides in cultured neurons. Neurosci. 1980, 5, 1647-1655.
12. Dunbar, G. L., L. L. Lescaudron & D. G. Stein: Comparison of GM1 ganglioside, AGF2, and D-Amphetamine as treatments for spatial reversal and place learning deficits following lesions of the neostriatum. Beh. Brain Res. 1993, 54, 67-79.
13. Dunn, A., D. Entingh, T. Entingh, W. H. Gispen, B. Machius, R. Perumal, H. D. Rees & L. Brogan: Biochemical correlates of brief behavioral experiences. In: The neurosciences: Third study program. Eds.: F. O. Schimidt & F. G. Worden. MIT Press, Cambridge, 1974, pp 679-684.
14. Elliot, P. J., L. Garofalo & A. C. Cuello: Limited neocortical devascularinzing lesions causing deficits in memory retention and choline acetyltransferase activity - effects of the monosialoganglioside GM1. Neurosci. 1989, 311, 63-677.
15. Fagioli, S., C. Casteliano, A. Oliverio & G. Toffano: Effect of chronic GM1 ganglioside administration on passive avoidance retention in mice. Neurosci. Letters 1990, 109, 212-216.
16. Fagioli, S., C. Rossi-Arnaud & C. Casteliano: Dose-dependent effect of GM1 ganglioside during development on inhibitory avoidance behaviour in mice: Influence of the period of administration. Psychopharmacology 1992, 109, 457-460.
17. Ferrari, G., M. Fabris & A. Gorio: Gangliosides enhance neurite outgrowth of PC12 cells. Der. Brain Res. 1983, 8, 215-221.
18. Garofalo, L. & A. C. Cuello: Nerve growth factor and the monosialoganglioside GM1. analogous and different in vivo effects on biochemical, morphological and behavioural parameters of adult cortically lesioned rats. Exp. Neurology 1994, 1252, 195-217.
19. Garofalo, L., Da Silva. A. Ribeiro & A. C. Cuello: Nerve growth factor-induced synaptogenesis and hypertrophy of cortical cholinergic terminals. Proceedings of the National Academy of Sciences of the United States of America 1992, 89, 2639-2643.
20. Gnahn, H., F. Hefti, R. Heumann, M. E. Schab & H. Thoenen: NGF-mediated increase of choline acetyltransferase CHAT in the neonatal rat forebrain, evidence for a physiological role of NGF in the brain? Der. Brain Res. 1983, 3, 229-238.
21. Gorio, A., G. Carmignoto, G. Ferrari, P. Marini & M. G. Nunzi: Plasticity and neuronal regeneration: implications for the role of exogenous gangliosides. Birth Defects 1983, 19, 157-174.
22. Hadjiconstantinou, M. & N. H. Neff: GM1 ganglioside: In vivo and in vitro trophic actions on central neurotransmitter systems. J. Neurochem. 1998, 70, 1335-1345.
23. Imhof, J. T., Z. M. I. Coelho, M. L. Schmitt, G. S. Morato & A. P. Carobrez: Influence of gender and age on performance of rats in the elevated plus maze apparatus. Beh. Brain Res. 1993, 56, 177-180.
24. Itoh, M., S. Fukumoto, N. Baba, Y. Kuga, A. Mizuno & K. Furukawa: Prevention of death of the rat axotomized hypoglossal nerve and promotion of its regeneration by bovine brain gangliosides. Glycobiology 1999, 9, 1247-1252.
25. Johnston, M. V., M. McKinney & J. T. Coyie: Evidence for a cholinergic projection to neocortex from neurons in basal forebrain. Proceedings of the National Academy of Sciences of the United States of America 1979, 76, 5392-5396.
26. Karpiak, S. E.: Ganglioside treatment improves recovery of alteration behavior after unilateral entorhinal cortex lesion. Exp. Neurol. 1983, 81, 330-339.
27. Karpiak, S. E. & M. M. Rapport: Inhibition of consolidation and retrieval stage of passive avoidance learning by antibodies to gangliosides. Beh. Neural Biol. 1979, 27, 146-156.
28. Karpiak, S. E., L. Graf & M. M. Rapport: Antibodies to GM1 ganglioside inhibit a learned avoidance response. Brain Res. 1978, 151, 637-640.
29. Karpiak, S. E., F. Vilim & S. P. Mahadik: Gangliosides accelerate rat neonatal learning and levels of cortical acetylcholinesterases. Dev. Neurosci. 1984, 6, 127-135.
30. Kasarskis, E. J., S. E. Karpiak, M. M. Rapport, R. K. Yu & N. H. Bass: Abnormal maturation of cerebral cortex and behavior in adult rats after neonatal administration of antibodies to GM1 ganglioside. Brain Res. 1981, 227, 25-35.
31. Kleinebeckel, D.: Acceleration of muscle re-innervation in rats by ganglioside treatment: an electromyographic study. Eur. J. Pharmacol. 1982, 80, 243-245.
32. Leon, A., L. Facci, D. Benvegnu & G. Toffano: Morphological and biochemical effects of gangliosides in neuroblastoma cells. Dev. Neurosci. 1982, 5, 108-114.
33. Mahadik, S. P. & S. E. Karpiak: GM1 ganglioside enhances neonatal cortical development. Neurotoxicol. 1986, 7, 161-168.
34. Mobley, W. C., J. L. Rutkowski, G. I. Tennekoon, J. Gemski, K. Buchanan & M. V. Johnston: Nerve growth factor increases choline acetyltranferase activity in developing basal forebrain neurons. Mol. Brain Res. 1986, 1, 53-62.
35. Palermo-Neto, J., R. Frussa-Filho & M. A. B. F. Vital: Kinetic analysis of GM1 effects on haloperidol-induced dopaminergic supersensitivity. General Pharmacology 1999, 32, 265-270.
36. Palumbo, M. A., C. Salvestroni, R. Gallo, A. L. Guo, A. D. Genazzani, P. G. Artini, F. Petraglia & A. R. Genazzani: Allopregnanolone concentration in hippocampus of prepubertal rats and female rats throughout estrous cycle. J. Endocrinol. Invest. 1995, 18, 853-856.
37. Panni, M. K., J. D. Cooper & M. V. Sonofroniew: Ganglioside GM1 potentiates NGF action on axotomised medial septal cholinergic neurons. Brain Res. 1998, 812, 76-80.
38. Rahmann, H.: Brain gangliosides: neuromodulators for synaptic transmission and memory formation. In: Advances in the biosciences. Pergamon Press, Oxford, 1986, pp. 235-245.
39. Ramirez, J. J., B. Fass, T. Kilfoil, B. Henschel, W. Grones & S. E. Karpiak: Ganglioside-induced enhancement of behavioral recovery after bilateral lesions of the entorhinal cortex. Brain Res. 1987, 414, 85-90.
40. Rapport, M. M.: Introduction to the biochemistry of gangliosides. In: Gangliosides in neurological and neuromuscular function, development and repair. Ed.: M. M. Rapport & A. Gorio. Raven Press, New York, 1981, pp. 15-19.
41. Ricceri, L., E. Alleva, F. Chiarotti & G. Calamandrei: Nerve growth factor affects passive avoidance learning and retention in developing mice. Brain Res. Bull. 1996, 39, 219-226.
42. Roisen, F. J., H. Bartfeld, R. Nagele & G. Yorke: Ganglioside stimulation of axonal sprouting in vitro. Science 1981, 214, 577-578.
43. Sabel B. A., M. D. Slavin & D. G. Stein: GM1 ganglioside treatment facilitates behavioural recovery from bilateral brain damage. Science 1984, 225, 340-342.
44. Schneider, J. S., J. A. Schroeder & D. S. Rothblat: Differential recovery of sensorimotor function in GM1 ganglioside-treated vs. spontaneously recovered MPTP-treated cats: partial striatal dopaminergic reinnervation vs. neurochemical compensation. Brain Res. 1998, 813, 82-87.
45. Silva, R. H., L. F. Felicio, A. G. Nasello, M. A. B. F. Vital & R. Frussa-Filho: Effects of ganglioside GM1 on memory in senescent rats. Neurobiol. Aging 1996, 144, 582-586.
46. Silva, R. H., R. G. Bellot, M. A. B. F. Vital & R. Frussa-Filho: Effects of long-term ganglioside GM1 administration on a new discriminative avoidance test in normal adult mice. Psychopharmacology 1997, 129, 322-328.
47. Silva, R. H., L. F. Felicio & R. Frussa-Filho: Ganglioside GM1 attenuates scopolamine-induced amnesia in rats and mice. Psychopharmacology 1999, 141, 111-117.
48. Skrivanek, J. A., R. W. Ledeen, R. U. Margolis & R. K. Margolis: Gangliosides associated with microsomal subtractions of brain: comparison with synaptic plasma membranes. J. Neurobiol. 1982, 13, 95-106.
49. Tettamanti, G., S. Sonnino, R. Ghiondi, M. Masserini & B. Venerando: Chemical and functional properties of gangliosides. Their possible implication in the membrane mediated transfer of information. In: Physics and amphiphiles. Miscelles, vesicles and microemulsions. XC Corso Soc. Ital. Fisica, 1985, pp. 607-636.
50. Toffano, G, L. F. Agnati & K. G. Fuxe: The effect of the ganglioside GM1 on neuronal plasticy. Int. J. Dev. Neurosci. 1986, 4, 97-100.
51. Vital, M. A. B. F., R. Frussa-Filho & J. Palermo-Neto: Effects of monosialoganglioside on dopaminergic supersensitivity. Life Sci. 1995, 56, 2299-2307.
52. Vital, M. A. B. F., R. Frussa-Filho & J. Palermo-Neto: Effects of monosialoganglioside on a new model of tardive dyskinesia. Progr. Neuro-Psychopharmacol. Biol. Psychiatry 1997, 21, 1169-1179.
53. 2 receptor binding and dopamine turnover. Life Sci. 1998, 62, 1161-1169.